Home/Filings/4/0001415889-25-018013
4//SEC Filing

GLENN JOHN 4

Accession 0001415889-25-018013

CIK 0001325618other

Filed

Jun 22, 8:00 PM ET

Accepted

Jun 23, 8:00 PM ET

Size

8.7 KB

Accession

0001415889-25-018013

Insider Transaction Report

Form 4
Period: 2025-06-20
GLENN JOHN
CHIEF FINANCIAL OFFICER
Transactions
  • Tax Payment

    Common Stock

    2025-06-20$58.24/sh1,412$82,23513,151 total
  • Exercise/Conversion

    Common Stock

    2025-06-20+5,79614,563 total
  • Exercise/Conversion

    Restricted Stock Units

    2025-06-205,7965,796 total
    Common Stock (5,796 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock that the Reporting Peron received upon the vesting of restricted stock units ("RSUs") on a one-for-one basis.
  • [F2]On June 20, 2022, the Reporting Person received RSUs under Iradimed Corporation's 2014 Equity Incentive Plan. The RSUs vest in four equal annual installments beginning on June 20, 2023. Upon vesting, the Reporting Person will receive a number of shares of common stock equal to the number of RSUs that have vested.

Issuer

IRADIMED CORP

CIK 0001325618

Entity typeother

Related Parties

1
  • filerCIK 0001253497

Filing Metadata

Form type
4
Filed
Jun 22, 8:00 PM ET
Accepted
Jun 23, 8:00 PM ET
Size
8.7 KB